PHARMACOLOGICAL SCREENING OF ANTI-OBESITY POTENTIAL OF ACORUS CALAMUS LINN. IN HIGH FAT CAFETERIA DIET FED OBESE RATS
Objective: To study the anti-obesity potential of aqueous rhizome extract of Acoruscalamus Linn. (AREAC)in high fat diet fed obese rats.
Methods: Adult strain male Wistar rats used in this study were fed with High Fat Diet (HFD) for 60 days. For the treatment groups,AREAC was administered in a dose levels of100, 200 and 300 mg/kgbw, orally once a day along with HFD. Rats fed with normal pellet chow were served as normal control. The effect of AREAC on physical parameterssuch as body weight, organ weight, fat pad weights and various biochemical parameterslike serum glucose, insulin, leptin,lipid profile, liver markers, kidney markers and oxidative stress markers were analysed.In-vitro pancreatic lipase inhibition assay of AREAC was also studied.
Results: Data of in-vivo studies revealedsignificant (p<0.05) reduction in percentage body weight gain, organ weights, fat pad weights and levels of serum glucose, insulin and leptin after treatment with AREAC in a dose dependent manner. Also, administration of AREAC significantly inhibited the increases in the concentrations of triglycerides, total cholesterol, LDL-cholesterol, VLDL-cholesterol, free-fatty acid and phospholipids in a dose dependent manner whereas, the level of HDL-cholesterol was found to be elevated on treatment. Moreover, on treatment with test drug,the elevated levels of serum liver and kidney markerssuch as AST, ALT, ALP, urea, creatinine were also brought back to near normalcy. Antioxidant status was found to be enhanced in liver tissues after treatment.In-vitro studies showed significant inhibition in the activity of pancreatic lipaseby AREAC.
Conclusion: The data of the results obtained clearly depicted that AREAC was found to have pronounced anti-obesity activity particularly at the dose levels of 300 mg/kg bw.
KeyWords: Obesity, High Fat Diet, Leptin, AcoruscalamusLinn., Orlistat.
2. Athesh K, Karthiga D, Brindha P. Anti-obesity effect of Carica papaya L. in rats fed on high fat cafeteria diet. Int J Pharm Pharm Sci 2012;4(5):327-30.
3. Manson JE, Willett WC, Stampfer MJ, Colditz GA, Hunter DJ, Hankinson SE, et al. Body weight and mortality among women. N Engl J Med 1995;333(11):677-85.
4. Niravel A, Smolar EN. Current concepts and future directions in the battle against obesity. Compr Ther 2004;30(3):164-72.
5. Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of obesity and trends in body mass index among US children and adolescents, 1999-2010. JAMA 2012;307(5):483-90.
6. Ayyad C, Andersen T. Long-term efficacy of dietary treatment of obesity: A systematic review of studies published between 1931 and 1999. Obes Rev 2000;1(2):113-9.
7. Dulloo AG. Ephedrine, xanthines and prostaglandin-inhibitors: Actions and interactions in the stimulation of thermogenesis. Int J Obes Relat Metab Disord 1993;17 Suppl 1:S35-40.
8. Sivalokanathan S, Ilayara M, Balasubramanian MP. Efficacy of Terminalia arjuna (Roxb.) on N-nitrosodiethylamine induced hepatocellular carcinoma in rats. Indian J Exp Biol 2005;43(3):264-7.
9. Verma RK, Paraidathathu T. Herbal medicines used in the traditional Indian medicinal system as a therapeutic treatment option for overweight and obesity management: A review. Int J Pharm Pharm Sci 2014;6(2):40-7.
10. Gamble JS. Flora of Presidency of Madras. Vol. II. India: Botanical Survey of India; 1997. p. 665-7.
11. Moro CO, Basile G. Obesity and medicinal plants. Fitoterapia 2000;71 Suppl 1:S73-82.
12. Xu BJ, Han LK, Zheng YN, Lee JH, Sung CK. In vitro inhibitory effect of triterpenoidal saponins from Platycodi Radix on pancreatic lipase. Arch Pharm Res 2005;28(2):180-5.
13. Verger R. Pancreatic lipase. In: Borgstrom B, Brockman HL, editors. Lipase. Amsterdam: Elsevier; 1984. p. 83-150.
14. Yun JW. Possible anti-obesity therapeutics from nature â€“ A review. Phytochemistry 2010;71(14-15):1625-41.
15. Prins JB, Oâ€™Rahilly S. Regulation of adipose cell number in man. Clin Sci (Lond) 1997;92(1):3-11.
16. Kang M, Oh JW, Lee HK, Chung HS, Lee SM, Kim C, et al. Anti-obesity effect of PM-F2-OB, an anti-obesity herbal formulation, on rats fed a high-fat diet. Biol Pharm Bull 2004;27(8):1251-6.
17. Charles MA, EschwÃ¨ge E, Thibult N, Claude JR, Warnet JM, Rosselin GE, et al. The role of non-esterified fatty acids in the deterioration of glucose tolerance in Caucasian subjects: Results of the Paris prospective study. Diabetologia 1997;40(9):1101-6.
18. Kahn BB, Flier JS. Obesity and insulin resistance. J Clin Invest 2000;106(4):473-81.
19. Lin S, Thomas TC, Storlien LH, Huang XF. Development of high fat diet-induced obesity and leptin resistance in C57Bl/6J mice. Int J Obes Relat Metab Disord 2000;24(5):639-46.
20. Lin L, Martin R, Schaffhauser AO, York DA. Acute changes in the response to peripheral leptin with alteration in the diet composition. Am J Physiol Regul Integr Comp Physiol 2001;280(2):R504-9.
21. Yao Y, Li XB, Zhao W, Zeng YY, Shen H, Xiang H, et al. Anti-obesity effect of an isoflavone fatty acid ester on obese mice induced by high fat diet and its potential mechanism. Lipids Health Dis 2010;9:49.
22. Guyton AC, Hall JE. In: Guyton AC, editor. Textbook of Medical Physiology. Philadelphia, PA: WB. Saunders Company; 1996. p. 869-99.
23. Zhao HL, Sim JS, Shim SH, Ha YW, Kang SS, Kim YS. Antiobese and hypolipidemic effects of platycodin saponins in diet-induced obese rats: Evidences for lipase inhibition and calorie intake restriction. Int J Obes (Lond) 2005;29(8):983-90.
24. Lydia K, William G, Vidya G, Latha D. Dietary supplementation of fructo oligosaccharides reduces hepatic steatosis associated with insulin resistance in obese zucker rats. Funct Foods Health Dis 2011;5:199-213.
25. Vajro P, Mandato C, Franzese A, Ciccimarra E, Lucariello S, Savoia M, et al. Vitamin E treatment in pediatric obesity-related liver disease: A randomized study. J Pediatr Gastroenterol Nutr 2004;38(1):48-55.
26. Nakano T, Kanmuri T, Sato M, Takeuchi M. Effect of astaxanthin rich red yeast (Phaffia rhodozyma) on oxidative stress in rainbow trout. Biochim Biophys Acta 1999;1426(1):119-25.
27. Norazmir MN Jr, Ayub MY. Beneficial lipid-lowering effects of pink guava puree in high fat diet induced-obese rats. Malays J Nutr 2010;16(1):171-85.
28. Cindik N, Baskin E, Agras PI, Kinik ST, Turan M, Saatci U. Effect of obesity on inflammatory markers and renal functions. Acta Paediatr 2005;94(12):1732-7.
29. Poirier B, Lannaud-Bournoville M, Conti M, Bazin R, Michel O, BariÃ©ty J, et al. Oxidative stress occurs in absence of hyperglycaemia and inflammation in the onset of kidney lesions in normotensive obese rats. Nephrol Dial Transplant 2000;15(4):467-76.
30. Kume S, Uzu T, Araki S, Sugimoto T, Isshiki K, Chin-Kanasaki M, et al. Role of altered renal lipid metabolism in the development of renal injury induced by a high-fat diet. J Am Soc Nephrol 2007;18(10):2715-23.
31. Pillai CK, Pillai KS. Antioxidants in health. Indian J Physiol Pharmacol 2002;46(1):1-5.
32. Olusi SO. Obesity is an independent risk factor for plasma lipid peroxidation and depletion of erythrocyte cytoprotectic enzymes in humans. Int J Obes Relat Metab Disord 2002;26(9):1159-64.
33. Joy J, Nair CK. Amelioration of cisplatin induced nephrotoxicity in Swiss albino mice by Rubia cordifolia extract. J Cancer Res Ther 2008;4(3):111-5.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.